122 related articles for article (PubMed ID: 38300021)
1. Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration.
Garcia-Fossa F; de Jesus MB
Nanotoxicology; 2024 Feb; 18(1):36-54. PubMed ID: 38300021
[TBL] [Abstract][Full Text] [Related]
2. Exploring the interplay between the TGF-
Moraes-Lacerda T; Garcia-Fossa F; de Jesus MB
Nanotechnology; 2024 May; 35(32):. PubMed ID: 38688253
[TBL] [Abstract][Full Text] [Related]
3. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.
Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E
Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.
Minelli R; Serpe L; Pettazzoni P; Minero V; Barrera G; Gigliotti C; Mesturini R; Rosa AC; Gasco P; Vivenza N; Muntoni E; Fantozzi R; Dianzani U; Zara GP; Dianzani C
Br J Pharmacol; 2012 May; 166(2):587-601. PubMed ID: 22049973
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
Biochem Biophys Res Commun; 2023 Jul; 664():69-76. PubMed ID: 37141640
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells.
Moraes-Lacerda T; de Jesus MB
Colloids Surf B Biointerfaces; 2022 Dec; 220():112863. PubMed ID: 36272282
[TBL] [Abstract][Full Text] [Related]
8. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
9. Drug targeting using solid lipid nanoparticles.
Rostami E; Kashanian S; Azandaryani AH; Faramarzi H; Dolatabadi JE; Omidfar K
Chem Phys Lipids; 2014 Jul; 181():56-61. PubMed ID: 24717692
[TBL] [Abstract][Full Text] [Related]
10. Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo.
Zhang X; Lu T; Ma Y; Li R; Pang Y; Mao H; Liu P
Onco Targets Ther; 2020; 13():5069-5082. PubMed ID: 32606729
[TBL] [Abstract][Full Text] [Related]
11. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
12. Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery.
Bondi ML; Azzolina A; Craparo EF; Lampiasi N; Capuano G; Giammona G; Cervello M
J Drug Target; 2007 May; 15(4):295-301. PubMed ID: 17487698
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
Chen X; Peng LH; Shan YH; Li N; Wei W; Yu L; Li QM; Liang WQ; Gao JQ
Int J Pharm; 2013 Apr; 447(1-2):171-81. PubMed ID: 23500766
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
Minelli R; Occhipinti S; Gigliotti CL; Barrera G; Gasco P; Conti L; Chiocchetti A; Zara GP; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C
Br J Pharmacol; 2013 Sep; 170(2):233-44. PubMed ID: 23713413
[TBL] [Abstract][Full Text] [Related]
16. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.
Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W
Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923
[TBL] [Abstract][Full Text] [Related]
17. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells.
Doktorovová S; Santos DL; Costa I; Andreani T; Souto EB; Silva AM
Int J Pharm; 2014 Aug; 471(1-2):18-27. PubMed ID: 24836663
[TBL] [Abstract][Full Text] [Related]
18. Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin.
Landim BC; de Jesus MM; Bosque BP; Zanon RG; da Silva CV; Góes RM; Ribeiro DL
Prostate; 2018 Jul; 78(10):731-742. PubMed ID: 29635803
[TBL] [Abstract][Full Text] [Related]
19. Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.
Oner E; Kotmakci M; Baird AM; Gray SG; Debelec Butuner B; Bozkurt E; Kantarci AG; Finn SP
J Nanobiotechnology; 2021 Mar; 19(1):71. PubMed ID: 33685469
[TBL] [Abstract][Full Text] [Related]
20. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer.
Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
